Loading stock data…
$15.50+0.04 (+0.26%)
USANA Health Sciences, Inc.
USANA Health Sciences, Inc. in the Consumer Defensive sector is trading at $15.50 with a market capitalization of $261M. Wall Street consensus targets $25.00 (1 analysts), implying a +61.3% move over the next 12 months. The stock is currently 34% below its 52-week high of $23.59, remaining 15.9% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 75 is overbought against a weak tape. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $223.27M↓ | $250.22M↑ | $226.20M↑ | $213.67M↓ | $235.85M |
| Gross Profit | $174.93M↓ | $190.78M↑ | $176.79M↑ | $164.85M↓ | $185.66M |
| Operating Income | $9.14M↓ | $13.87M↓ | $17.25M↑ | $1.22M↓ | $16.72M |
| Net Income | -$21.38M↓ | $6.96M↑ | -$1.77M↑ | -$6.52M↓ | $9.65M |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. Th...